1. Immune-Mediated Mechanisms in Cofactor-Dependent Food Allergy and Anaphylaxis: Effect of Cofactors in Basophils and Mast Cells
   Rosa Muñoz-Cano et al, 2021, Frontiers in Immunology CrossRef
2. Integrins as a drug target in liver fibrosis
   Syedia R. Rahman et al, 2022, Liver International CrossRef
3. ATP Secretion and Metabolism in Regulating Pancreatic Beta Cell Functions and Hepatic Glycolipid Metabolism
   Jing Li et al, 2022, Frontiers in Physiology CrossRef
4. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease
   Takefumi Kimura et al, 2021, Frontiers in Endocrinology CrossRef
5. Purinergic Signaling in Liver Pathophysiology
   Shanu Jain et al, 2021, Frontiers in Endocrinology CrossRef
6. Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gαi3 and GαoA Isoprotein Activation
   Courtney L. Fisher et al, 2022, ACS Pharmacology & Translational Science CrossRef
7. Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2
   Xiaoli Qian et al, 2021, Aging CrossRef
8. Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists
   Dilip K. Tosh et al, 2020, ACS Medicinal Chemistry Letters CrossRef
9. Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
   Pnina Fishman et al, 2023, Purinergic Signalling CrossRef
10. An Efficient Model of Non-alcoholic Fatty Liver Disease (NAFLD) Versus Current Experimental Models: Effects of Fructose, Fat, and Carbon Tetrachloride on NAFLD
    Zahra Eslami et al, 2021, Hepatitis Monthly CrossRef
11. Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
    Yajie Fu et al, 2022, Frontiers in Pharmacology CrossRef
12. Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis
    Yikuan Du et al, 2024, Current Stem Cell Research & Therapy CrossRef
13. Design and in vivo activity of A3 adenosine receptor agonist prodrugs
    R. Rama Suresh et al, 2020, Purinergic Signalling CrossRef
14. Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species
    R. Rama Suresh et al, 2022, ACS Medicinal Chemistry Letters CrossRef